The concept of using a balloon catheter to directly deliver an antiproliferative drug at the site
of injury has become one of the most interesting technological developments in …

Peripheral arterial disease most commonly affects the femoropopliteal segment. Despite
enormous improvements in device and treatment technology the long-term patency rate and …

Despite the progress in endovascular treatment of patients with peripheral arterial disease,
restenosis remains the major drawback, especially in patients with femoropopliteal lesions …

Even if recently the first positive results were presented for a paclitaxel releasing drug
eluting stent there are still concerns about stent implantation in the femoro-popliteal artery …

Within the last years, many new endovascular treatment modalities have been invented for
treatment of peripheral arterial disease. To leave nothing behind and to keep options for …

The use of drug-eluting balloons for treatment of long-segment femoropopliteal artery
obstructions has become widespread in recent years. The possibility to deliver a drug into …

The treatment of femoropopliteal lesions has known an important evolution in the last years.
An important limitation of current endovascular therapy remains the occurrence of …

Drug-coated balloon (DCB) technologies represent the latest and hottest development in the
field of endovascular treatment of peripheral arterial disease. Initial experience with …

Drug-coated balloons--the importance of packing and dosing antiproliferative drugs. - Abstract
- Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About Tools …

Local drug delivery of an anti-proliferative drug from balloon catheter systems to the site of
arterial injury has been attempted repeatedly over the years with limited success in drug …